CD40LG and Epstein-Barr virus infection: After a year of follow-up with the IRP patients, we found that the remission rate of patients with anti-EBVCA IgM positivity was significantly lower than that of patients with anti-EBVCA IgM negativity, indicating that EBV infection delays IRP remission.